Literature DB >> 28681919

Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients.

G Guggino1, M Lo Pizzo2,3, D Di Liberto2,3, A Rizzo4, P Cipriani5, P Ruscitti5, G Candore2, C M Gambino2, G Sireci2,3, F Dieli2,3, R Giacomelli5, G Triolo1, F Ciccia1.   

Abstract

T helper 9 (Th9) cells and interleukin (IL)-9 are involved in the pathogenesis of several autoimmune diseases. The exact role of IL-9 and Th9 cells in patients with systemic sclerosis (SSc) have not yet been studied adequately. IL-9, IL-9R, transcription factor PU.1 (PU.1), IL-4, thymic stromal lymphopoietin (TSLP) and transforming growth factor (TGF)-β expression were assessed in skin and kidney biopsies of SSc patients and healthy controls (HC) by immunohistochemistry (IHC). The cellular source of IL-9 was also analysed by confocal microscopy analysis. Peripheral IL-9-producing cells were also studied by flow cytometry. The functional relevance of IL-9 increased expression in SSc was also investigated. Our results demonstrated a strong expression of IL-9, IL-9R, IL-4, TSLP and TGF-β in skin tissues of patients with both limited and diffuse SSc. IL-9 expression was observed mainly in the context of skin infiltrating mononuclear cells and keratinizing squamous epithelium. IL-9 over-expression was also observed in renal biopsies of patients with SSc. IL-9 producing cells in the skin were identified as Th9 cells. Similarly, Th9 cells were expanded and were the major source of IL-9 among SSc peripheral blood mononuclear cells (PBMC), their percentage being correlated directly with the modified Rodnan skin score. Infiltrating mononuclear cells, mast cells and neutrophils expressed IL-9R. In in-vitro studies stimulation with rIL-9 significantly induced NET (neutrophil extracellular traps) release by dying cells (NETosis) in neutrophils, expansion of mast cells and increase of anti-systemic scleroderma 70 (Scl70) production by B cells. Our findings suggest that Th9 cells and IL-9 could be implicated in the pathogenesis of SSc.
© 2017 British Society for Immunology.

Entities:  

Keywords:  IL-9; ILC2; Th9; systemic sclerosis

Mesh:

Substances:

Year:  2017        PMID: 28681919      PMCID: PMC5629425          DOI: 10.1111/cei.13009

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis.

Authors:  C P Denton; J B Cailes; G D Phillips; A U Wells; C M Black; R M Bois
Journal:  Br J Rheumatol       Date:  1997-02

Review 2.  Involvement of mast cells in systemic sclerosis.

Authors:  Sonosuke Yukawa; Kunihiro Yamaoka; Norifumi Sawamukai; Shohei Shimajiri; Kazuyoshi Saito; Yoshiya Tanaka
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  2010

Review 3.  Interleukin-9 and T helper type 9 cells in rheumatic diseases.

Authors:  F Ciccia; G Guggino; A Ferrante; P Cipriani; R Giacomelli; G Triolo
Journal:  Clin Exp Immunol       Date:  2016-08       Impact factor: 4.330

4.  Regulation of IL-9 expression by IL-25 signaling.

Authors:  Pornpimon Angkasekwinai; Seon Hee Chang; Manoj Thapa; Hiroshi Watarai; Chen Dong
Journal:  Nat Immunol       Date:  2010-02-14       Impact factor: 25.606

5.  Polymorphonuclear neutrophil function in systemic sclerosis.

Authors:  L Czirják; K Dankó; S Sipka; M Zeher; G Szegedi
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

6.  Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor β.

Authors:  Romy B Christmann; Allison Mathes; Alsya J Affandi; Cristina Padilla; Banafsheh Nazari; Andreea M Bujor; Giuseppina Stifano; Robert Lafyatis
Journal:  Arthritis Rheum       Date:  2013-05

7.  Interleukin-25 (IL-25) promotes efficient protective immunity against Trichinella spiralis infection by enhancing the antigen-specific IL-9 response.

Authors:  Pornpimon Angkasekwinai; Potjanee Srimanote; Yui-Hsi Wang; Anek Pootong; Yuwaporn Sakolvaree; Kovit Pattanapanyasat; Wanpen Chaicumpa; Sansanee Chaiyaroj; Chen Dong
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

8.  High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.

Authors:  Paola Adele Lonati; Nicolò Costantino Brembilla; Elisa Montanari; Lionel Fontao; Armando Gabrielli; Serena Vettori; Gabriele Valentini; Emmanuel Laffitte; Gurkan Kaya; Pier-Luigi Meroni; Carlo Chizzolini
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

9.  A deleterious role for Th9/IL-9 in hepatic fibrogenesis.

Authors:  Shan-yu Qin; Dong-hong Lu; Xiao-yun Guo; Wei Luo; Bang-li Hu; Xiao-li Huang; Mei Chen; Jia-xu Wang; Shi-Jia Ma; Xian-wen Yang; Hai-xing Jiang; You Zhou
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

10.  IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation.

Authors:  Jan-Eric Turner; Peter J Morrison; Christoph Wilhelm; Mark Wilson; Helena Ahlfors; Jean-Christophe Renauld; Ulf Panzer; Helena Helmby; Brigitta Stockinger
Journal:  J Exp Med       Date:  2013-11-18       Impact factor: 14.307

View more
  11 in total

Review 1.  Kidney involvement in systemic sclerosis: From pathogenesis to treatment.

Authors:  Cosimo Bruni; Giovanna Cuomo; Francesca W Rossi; Emanuela Praino; Silvia Bellando-Randone
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

2.  Effect of crosstalk between Th17 and Th9 cells on the activation of dermal vascular smooth muscle cells in systemic scleroderma and regulation of tanshinone IIA.

Authors:  Mengguo Liu
Journal:  An Bras Dermatol       Date:  2022-09-15       Impact factor: 2.113

3.  IL-9 blockade attenuates inflammation in a murine model of mechanical ventilation-induced lung injury by inhibiting the NLRP3 inflammasome pathway.

Authors:  Tao Wang; Ziqi Chai; Lijuan Wang; Bo Liu; Junbo Zhao; Jie Ren; Bo Yang; Xiaoyong Wei; Lihua Jiang; Fuyun Liu
Journal:  Inflammopharmacology       Date:  2022-03-16       Impact factor: 5.093

4.  The Levels of Serum Serotonin Can Be Related to Skin and Pulmonary Manifestations of Systemic Sclerosis.

Authors:  Marin Petrić; Dijana Perković; Ivona Božić; Daniela Marasović Krstulović; Dušanka Martinović Kaliterna
Journal:  Medicina (Kaunas)       Date:  2022-01-21       Impact factor: 2.430

Review 5.  Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.

Authors:  Gabriela Kania; Michal Rudnik; Oliver Distler
Journal:  Nat Rev Rheumatol       Date:  2019-05       Impact factor: 20.543

6.  Anaphylatoxins enhance Th9 cell recruitment via the CCL20-CCR6 axis in IgA nephropathy.

Authors:  Xinyue Hu; Juntao Feng; Shuanglinzi Deng; Jiale Tang; Zhonghua Liao; Lisha Luo; Liying Luo; Ting Meng; Guanghui Gong; Xiaozhao Li
Journal:  J Nephrol       Date:  2020-02-08       Impact factor: 3.902

7.  Long Non-Coding RNAs Play a Role in the Pathogenesis of Psoriatic Arthritis by Regulating MicroRNAs and Genes Involved in Inflammation and Metabolic Syndrome.

Authors:  Marzia Dolcino; Andrea Pelosi; Piera Filomena Fiore; Giuseppe Patuzzo; Elisa Tinazzi; Claudio Lunardi; Antonio Puccetti
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

Review 8.  Contributions of Immune Cells and Stromal Cells to the Pathogenesis of Systemic Sclerosis: Recent Insights.

Authors:  Bingying Dai; Liqing Ding; Lijuan Zhao; Honglin Zhu; Hui Luo
Journal:  Front Pharmacol       Date:  2022-02-03       Impact factor: 5.810

Review 9.  Paraclinical Aspects in Systemic Sclerosis.

Authors:  Carmen Bobeica; Mihaela Craescu; Bogdan Ioan Stefanescu; Ciprian Dinu; Iulia Chiscop; Silvia Chirobocea; Luiza Nechita; Alina Viorica Iancu; Victorita Stefanescu; Gabriela Balan; Ioana Anca Stefanopol; Ana Maria Pelin; Elena Niculet; Carmina Liana Musat; Alin Laurentiu Tatu
Journal:  Int J Gen Med       Date:  2022-04-26

Review 10.  Thymic Stromal Lymphopoietin in Cutaneous Immune-Mediated Diseases.

Authors:  Si-Hang Wang; Ya-Gang Zuo
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.